ONCY

Oncolytics Biotech
$0.80
−$0.01 (−1.48%)Jul 27, 2026
0.4PoorMoatMint rating

MoatMint rates Oncolytics Biotech (ONCY) 0.4 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 1.4 out of 10.

Key metrics

The numbers that frame ONCY today
Market cap
$95.48M
P/E (TTM)
-2.9
EV / FCF
-4.0
ROIC
1,534.5%
Div yield
0%
52wk Low
$0.77
52wk High
$1.51

ONCY stock rating

How ONCY scores on quality, value, growth, momentum and financial health
0.4out of 10
Low overallNeutral business, expensive priceTop 96% of ~5,000 US stocks
QualityPoor1.4/10
GrowthPoor1.0/10
MomentumFair2.7/10
ValuePoor1.2/10
Financial HealthPoor1.4/10

Growth

Revenue and earnings trend for ONCY
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about ONCY
Is Oncolytics Biotech a good buy?
No. Oncolytics Biotech has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Oncolytics Biotech is selling at a very high price.
What is the market capitalization of ONCY?
Oncolytics Biotech's market capitalization is $95.48M.
What is the P/E ratio for ONCY stock?
Oncolytics Biotech's current P/E ratio is -2.9.
What is the 52-week high for ONCY stock?
The 52-week high for Oncolytics Biotech is $1.51. The current close of $0.80 is 47% below that high.
What is the 52-week low for ONCY stock?
The 52-week low for Oncolytics Biotech is $0.77. The current close of $0.80 is 3.9% above that low.
Does ONCY stock pay dividends?
Oncolytics Biotech does not currently show a dividend per share in the company data.